Cofco Tax Provision vs Total Revenue Analysis

000930 Stock

5.78 0.04 0.69%

Cofco Biochemical financial indicator trend analysis is way more than just evaluating Cofco Biochemical Anhui prevailing accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether Cofco Biochemical Anhui is a good investment. Please check the relationship between Cofco Biochemical Tax Provision and its Total Revenue accounts. Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Cofco Biochemical Anhui. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in nation.

Tax Provision vs Total Revenue

Tax Provision vs Total Revenue Correlation Analysis

The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of Cofco Biochemical Anhui Tax Provision account and Total Revenue. At this time, the significance of the direction appears to have very strong relationship.

The correlation between Cofco Biochemical's Tax Provision and Total Revenue is 0.84. Overlapping area represents the amount of variation of Tax Provision that can explain the historical movement of Total Revenue in the same time period over historical financial statements of Cofco Biochemical Anhui, assuming nothing else is changed. The correlation between historical values of Cofco Biochemical's Tax Provision and Total Revenue is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Tax Provision of Cofco Biochemical Anhui are associated (or correlated) with its Total Revenue. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Total Revenue has no effect on the direction of Tax Provision i.e., Cofco Biochemical's Tax Provision and Total Revenue go up and down completely randomly.

Correlation Coefficient

0.84

Relationship Direction	Positive
Relationship Strength	Strong

View All Relationships

Tax Provision

The amount set aside by a company to cover any estimated taxes for the current period. It reflects the company's expected tax liabilities.

Total Revenue

Total revenue comprises all receipts Cofco Biochemical Anhui generated from the sale of its products or services. The total amount of income generated by the sale of goods or services related to the company's primary operations.

Most indicators from Cofco Biochemical's fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into Cofco Biochemical Anhui current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Cofco Biochemical Anhui. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in nation.

The current year's Tax Provision is expected to grow to about 139.8 M, whereas Selling General Administrative is forecasted to decline to about 184.1 M.

	2021	2022	2023	2024 (projected)
EBITDA	2.0B	1.9B	2.2B	1.5B
Interest Income	15.4M	16.2M	16.2M	10.9M

Ebitda Interest Income

Cofco Biochemical fundamental ratios Correlations

	Total Assets	Other Current Liab	Total Current Liabilities	Total Stockholder Equity	Retained Earnings	Accounts Payable	Cash	Long Term Debt	Net Receivables	Inventory	Other Current Assets	Total Liab	Common Stock	Property Plant Equipment	Other Liab	Other Assets	Intangible Assets	Short Term Investments	Net Tangible Assets	Other Stockholder Equity	Deferred Long Term Liab	Long Term Investments	Short Long Term Debt	Total Current Assets	Short Term Debt	Non Current Assets Total
Total Assets		0.34	0.46	0.91	0.74	0.79	0.58	-0.31	0.6	0.94	0.4	0.9	0.85	0.83	0.54	0.17	0.86	-0.52	0.89	0.87	0.84	0.78	0.84	0.73	0.85	0.93
Other Current Liab	0.34		0.9	0.15	0.06	0.71	-0.02	0.14	0.88	0.49	0.91	0.47	0.16	0.55	-0.09	0.44	0.49	-0.28	0.27	0.47	0.56	0.48	0.42	0.71	0.29	0.25
Total Current Liabilities	0.46	0.9		0.32	0.16	0.79	0.24	-0.03	0.83	0.64	0.98	0.59	0.39	0.71	0.16	0.43	0.62	-0.45	0.45	0.63	0.69	0.67	0.64	0.87	0.48	0.39
Total Stockholder Equity	0.91	0.15	0.32		0.79	0.73	0.8	-0.5	0.48	0.82	0.27	0.72	0.94	0.78	0.69	0.01	0.8	-0.47	0.94	0.89	0.85	0.87	0.77	0.7	0.94	0.97
Retained Earnings	0.74	0.06	0.16	0.79		0.62	0.46	-0.3	0.31	0.75	0.14	0.43	0.62	0.69	0.55	-0.34	0.45	-0.37	0.74	0.65	0.59	0.57	0.46	0.48	0.61	0.69
Accounts Payable	0.79	0.71	0.79	0.73	0.62		0.52	-0.27	0.88	0.87	0.76	0.7	0.69	0.89	0.36	0.22	0.83	-0.43	0.81	0.89	0.92	0.88	0.76	0.92	0.79	0.77
Cash	0.58	-0.02	0.24	0.8	0.46	0.52		-0.55	0.37	0.48	0.13	0.42	0.87	0.59	0.74	0.2	0.63	-0.43	0.81	0.75	0.74	0.8	0.57	0.56	0.86	0.76
Long Term Debt	-0.31	0.14	-0.03	-0.5	-0.3	-0.27	-0.55		0.0	-0.27	-0.09	-0.11	-0.4	-0.22	-0.53	0.02	-0.4	-0.23	-0.56	-0.52	-0.47	-0.52	-0.44	-0.35	-0.58	-0.53
Net Receivables	0.6	0.88	0.83	0.48	0.31	0.88	0.37	0.0		0.66	0.79	0.63	0.51	0.75	0.16	0.46	0.71	-0.42	0.59	0.72	0.81	0.73	0.56	0.82	0.6	0.57
Inventory	0.94	0.49	0.64	0.82	0.75	0.87	0.48	-0.27	0.66		0.61	0.87	0.75	0.85	0.45	0.17	0.83	-0.49	0.83	0.85	0.83	0.79	0.87	0.85	0.79	0.84
Other Current Assets	0.4	0.91	0.98	0.27	0.14	0.76	0.13	-0.09	0.79	0.61		0.52	0.29	0.63	0.07	0.37	0.57	-0.3	0.39	0.58	0.65	0.63	0.62	0.86	0.43	0.35
Total Liab	0.9	0.47	0.59	0.72	0.43	0.7	0.42	-0.11	0.63	0.87	0.52		0.75	0.7	0.39	0.38	0.86	-0.56	0.68	0.73	0.71	0.68	0.88	0.73	0.73	0.8
Common Stock	0.85	0.16	0.39	0.94	0.62	0.69	0.87	-0.4	0.51	0.75	0.29	0.75		0.78	0.73	0.18	0.82	-0.66	0.88	0.86	0.83	0.87	0.76	0.69	0.93	0.92
Property Plant Equipment	0.83	0.55	0.71	0.78	0.69	0.89	0.59	-0.22	0.75	0.85	0.63	0.7	0.78		0.57	0.09	0.72	-0.66	0.86	0.9	0.9	0.86	0.71	0.83	0.78	0.77
Other Liab	0.54	-0.09	0.16	0.69	0.55	0.36	0.74	-0.53	0.16	0.45	0.07	0.39	0.73	0.57		-0.08	0.4	-0.55	0.63	0.57	0.53	0.58	0.47	0.41	0.65	0.61
Other Assets	0.17	0.44	0.43	0.01	-0.34	0.22	0.2	0.02	0.46	0.17	0.37	0.38	0.18	0.09	-0.08		0.47	-0.24	0.11	0.2	0.27	0.21	0.3	0.3	0.22	0.14
Intangible Assets	0.86	0.49	0.62	0.8	0.45	0.83	0.63	-0.4	0.71	0.83	0.57	0.86	0.82	0.72	0.4	0.47		-0.43	0.81	0.87	0.87	0.85	0.87	0.82	0.88	0.87
Short Term Investments	-0.52	-0.28	-0.45	-0.47	-0.37	-0.43	-0.43	-0.23	-0.42	-0.49	-0.3	-0.56	-0.66	-0.66	-0.55	-0.24	-0.43		-0.4	-0.43	-0.43	-0.43	-0.37	-0.41	-0.42	-0.39
Net Tangible Assets	0.89	0.27	0.45	0.94	0.74	0.81	0.81	-0.56	0.59	0.83	0.39	0.68	0.88	0.86	0.63	0.11	0.81	-0.4		0.97	0.94	0.92	0.78	0.77	0.95	0.95
Other Stockholder Equity	0.87	0.47	0.63	0.89	0.65	0.89	0.75	-0.52	0.72	0.85	0.58	0.73	0.86	0.9	0.57	0.2	0.87	-0.43	0.97		0.99	0.97	0.83	0.88	0.95	0.93
Deferred Long Term Liab	0.84	0.56	0.69	0.85	0.59	0.92	0.74	-0.47	0.81	0.83	0.65	0.71	0.83	0.9	0.53	0.27	0.87	-0.43	0.94	0.99		0.97	0.8	0.91	0.93	0.89
Long Term Investments	0.78	0.48	0.67	0.87	0.57	0.88	0.8	-0.52	0.73	0.79	0.63	0.68	0.87	0.86	0.58	0.21	0.85	-0.43	0.92	0.97	0.97		0.82	0.92	0.95	0.89
Short Long Term Debt	0.84	0.42	0.64	0.77	0.46	0.76	0.57	-0.44	0.56	0.87	0.62	0.88	0.76	0.71	0.47	0.3	0.87	-0.37	0.78	0.83	0.8	0.82		0.86	0.84	0.84
Total Current Assets	0.73	0.71	0.87	0.7	0.48	0.92	0.56	-0.35	0.82	0.85	0.86	0.73	0.69	0.83	0.41	0.3	0.82	-0.41	0.77	0.88	0.91	0.92	0.86		0.81	0.76
Short Term Debt	0.85	0.29	0.48	0.94	0.61	0.79	0.86	-0.58	0.6	0.79	0.43	0.73	0.93	0.78	0.65	0.22	0.88	-0.42	0.95	0.95	0.93	0.95	0.84	0.81		0.97
Non Current Assets Total	0.93	0.25	0.39	0.97	0.69	0.77	0.76	-0.53	0.57	0.84	0.35	0.8	0.92	0.77	0.61	0.14	0.87	-0.39	0.95	0.93	0.89	0.89	0.84	0.76	0.97

Click cells to compare fundamentals

Cofco Biochemical Account Relationship Matchups

Cofco Biochemical fundamental ratios Accounts

	2019	2020	2021	2022	2023	2024 (projected)
Total Assets	17.2B	20.5B	18.1B	18.1B	16.6B	9.9B
Other Current Liab	2.5B	1.3B	1.4B	952.6M	30.2M	28.7M
Total Current Liabilities	6.5B	9.3B	5.6B	5.2B	5.1B	4.9B
Total Stockholder Equity	9.8B	10.4B	11.4B	12.1B	10.5B	11.0B
Retained Earnings	1.3B	1.8B	2.8B	3.2B	1.4B	824.6M
Accounts Payable	854.8M	845.8M	920.2M	919.6M	766.5M	615.6M
Cash	700.5M	662.3M	1.1B	1.0B	1.5B	1.6B
Long Term Debt	274.7M	189.7M	406.4M	191.3M	165.6M	157.4M
Net Receivables	1.4B	734.5M	1.5B	1.1B	1.0B	742.2M
Inventory	2.8B	5.0B	4.1B	3.8B	2.5B	1.6B
Other Current Assets	1.8B	2.9B	982.0M	1.3B	485.7M	819.8M
Total Liab	7.0B	9.7B	6.3B	5.6B	5.7B	5.1B
Property Plant Equipment	8.2B	8.5B	8.5B	8.6B	9.9B	5.5B
Other Liab	108.3M	125.8M	169.6M	189.2M	217.6M	228.4M
Other Assets	522.8M	354.3M	400.0M	306.4M	352.3M	337.1M
Intangible Assets	823.9M	852.7M	629.7M	610.6M	602.7M	632.8M
Net Tangible Assets	8.6B	9.2B	10.4B	11.1B	12.8B	7.4B
Other Stockholder Equity	683.1M	651.2M	616.9M	692.8M	796.8M	521.5M
Deferred Long Term Liab	26.7M	27.2M	22.2M	25.2M	29.0M	20.5M
Short Long Term Debt	2.5B	6.6B	2.8B	2.9B	3.2B	3.3B
Total Current Assets	6.7B	9.9B	7.6B	7.7B	6.0B	7.5B
Non Current Assets Total	10.4B	10.6B	10.4B	10.4B	10.5B	9.8B
Non Currrent Assets Other	121.0M	198.8M	(86.5M)	109.4M	80.0M	95.1M
Non Current Liabilities Total	412.7M	359.3M	712.9M	427.3M	562.5M	499.8M
Net Debt	2.1B	6.1B	2.1B	2.0B	1.9B	2.4B
Net Invested Capital	12.6B	17.2B	14.6B	15.2B	13.8B	14.6B
Net Working Capital	186.6M	578.0M	2.0B	2.5B	893.5M	700.6M

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

C	Citigroup
GM	General Motors
F	Ford Motor

Other Information on Investing in Cofco Stock

Balance Sheet is a snapshot of the financial position of Cofco Biochemical Anhui at a specified time, usually calculated after every quarter, six months, or one year. Cofco Biochemical Balance Sheet has two main parts: assets and liabilities. Liabilities are the debts or obligations of Cofco Biochemical and are divided into current liabilities and long term liabilities. An asset, on the other hand, is anything of value that can be converted into cash and which Cofco currently owns. An asset can also be divided into two categories, current and non-current.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC

Cofco Tax Provision vs Total Revenue Analysis

Tax Provision vs Total Revenue

Tax Provision vs Total Revenue Correlation Analysis

Correlation Coefficient

Tax Provision

Total Revenue

Cofco Biochemical fundamental ratios Correlations

Cofco Biochemical Account Relationship Matchups

High Positive Relationship

High Negative Relationship

Cofco Biochemical fundamental ratios Accounts

Also Currently Popular

Other Information on Investing in Cofco Stock

COMMON DESTINATIONS

MAIN CATEGORIES

COMPANY

Deferred Long Term Liab	+ 0.99	Other Stockholder Equity
Other Current Assets	+ 0.98	Total Current Liabilities
Non Current Assets Total	+ 0.97	Total Stockholder Equity
Other Stockholder Equity	+ 0.97	Net Tangible Assets
Long Term Investments	+ 0.97	Other Stockholder Equity
Long Term Investments	+ 0.97	Deferred Long Term Liab

Short Term Investments	- 0.66	Property Plant Equipment
Short Term Investments	- 0.66	Common Stock
Short Term Debt	- 0.58	Long Term Debt
Short Term Investments	- 0.56	Total Liab
Net Tangible Assets	- 0.56	Long Term Debt
Short Term Investments	- 0.55	Other Liab